Example: Heart Attack

Search clinical trials for: Roflumilast Placebo

Total 50 results

NCT05884281

Not yet recruiting

Efficacy of Roflumilast in Prevention of Peripheral Neuropathy

Peripheral Neuropathy
NCT05682859

Not yet recruiting

Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)

Chronic Hand Eczema
NCT05418049

Recruiting

Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge

Fragile X Syndrome
NCT04751071

Recruiting

The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Major Depressive Disorder
NCT04658654

Recruiting

Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients (ROMEMA)

Mild Cognitive Impairment | Mild Dementia | Amnestic Mild Cognitive Disorder
NCT04636814

Recruiting

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) (PILLAR)

Chronic Obstructive Pulmonary Disease
NCT04108377

Recruiting

Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma

Asthma
NCT05763082

Completed

Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Plaque Psoriasis
NCT04091646

Completed

Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Seborrheic Dermatitis
NCT02363335

Completed

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

Healthy Volunteers
NCT04128007

Completed

Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis

Plaque Psoriasis
NCT03532490

Completed

Trial of Roflumilast in Asthma Management (TRIM) (TRIM)

Obesity | Asthma
NCT04800172

Completed

The Possible Effects of Roflumilast on Obesity Related Disorders

Obesity | PreDiabetes
NCT04744090

Completed

Roflumilast as add-on Therapy in Early Cases of ARDS

Respiratory Distress Syndrome, Adult
NCT04369547

Withdrawn

Roflumilast TMS-EEG Plasticity

Synaptic Plasticity
NCT04755946

Unknown

Possible Role of Roflumilast in Diabetic Nephropathy

Diabetic Nephropathies
NCT01973998

Completed

Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization

COPD
NCT03988816

Unknown

Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis

Bronchiectasis Adult
NCT01433666

Completed

Roflumilast and Cognition (EEGrofl)

Dementia
NCT01509677

Completed

Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | COPD
NCT04122547

Completed

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis

Bronchiectasis | Lung Function Decreased | Exacerbation Copd
NCT02671942

Terminated

A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients

Chronic Obstructive Pulmonary Disease
NCT01630200

Completed

Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD) (ELASTIC)

Chronic Obstructive Pulmonary Disease and Allied Conditions
NCT02451540

Terminated

Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging

Pulmonary Disease, Chronic Obstructive
NCT02097992

Completed

Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD

COPD
NCT03073798

Completed

The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis

Emphysema | COPD | Chronic Bronchitis
NCT02165826

Completed

Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD (OPTIMIZE)

Chronic Obstructive Pulmonary Disease (COPD)
NCT01443845

Completed

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Lung Diseases | Pulmonary Disease | COPD | COPD Exacerbation | Respiratory Disorders | Chronic Obstructive Airway Disease | Chronic Obstructive Lung Diseases
NCT01730404

Completed

Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients

COPD
NCT01473758

Terminated

Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease (TREAT)

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation
NCT02051335

Completed

Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults

Alzheimer's Disease | Memory Impairment
NCT01765192

Completed

Roflumilast Plus Montelukast in Adults With Severe Asthma

Asthma
NCT01664624

Completed

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Type 2 Diabetes
NCT01313494

Completed

A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore: (ACROSS)

COPD
NCT01703260

Terminated

Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

Nonalcoholic Steatohapatitis
NCT00297102

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)

Chronic Obstructive Pulmonary Disease (COPD)
NCT00313209

Completed

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127) (EOS)

Chronic Obstructive Pulmonary Disease (COPD)
NCT01329029

Completed

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) (REACT)

Chronic Obstructive Pulmonary Disease
NCT00424268

Completed

Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128) (HELIOS)

Chronic Obstructive Pulmonary Disease
NCT00746434

Withdrawn

A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis

Plaque Psoriasis
NCT00242320

Completed

Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)

COPD
NCT00746382

Withdrawn

A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)

Dermatitis
NCT00297115

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

Chronic Obstructive Pulmonary Disease (COPD)
NCT01365533

Completed

A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

Allergic Asthma
NCT02079844

Completed

Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

Schizophrenia
NCT01830959

Unknown

Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS) (REFS)

Sarcoidosis
NCT01572948

Completed

A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)

COPD
NCT01701934

Terminated

Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (RAMBO)

Chronic Obstructive Pulmonary Disease | Metabolic Syndrome
NCT01480661

Completed

Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients

Pulmonary Disease, Chronic Obstructive
NCT01595750

Unknown

Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease (REVASC)

Chronic Obstructive Pulmonary Disease

Search clinical trials for: Roflumilast Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations